Everolimus Tablet · 193 days since initial FDA posting
Brand: EVEROLIMUS
FDA lists Everolimus Tablet as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Everolimus Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Everolimus Tablet
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Everolimus, Tablet, 10 mg (NDC 0093-7769-24)
- Package NDC
- 0093-7769-24
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Mar 2, 2026
- Last Updated
- Mar 2, 2026
- Therapeutic Category
- Transplant
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Nearby, Other Everolimus Shortage Records
Everolimus Tablet
Mylan Pharmaceuticals Inc., a Viatris Company
Tablet
Everolimus Tablet
Mylan Pharmaceuticals Inc., a Viatris Company
Tablet
Everolimus Tablet
Mylan Pharmaceuticals Inc., a Viatris Company
Tablet
Everolimus Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Everolimus Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
Everolimus Tablet
Teva Pharmaceuticals USA, Inc.
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.